Blue Owl Capital Holdings’s Larimar Therapeutics LRMR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$32M	Buy	7,120,007 +296,317	+4%	+$1.18M	8.68%	2
2025 Q4	$26M	Buy	6,823,690 +970,650	+17%	+$3.78M	8.02%	4
2025 Q3	$18.9M	Buy	5,853,040 +925,000	+19%	+$3.47M	5.87%	4
2025 Q2	$14.2M	Buy	4,928,040 +150,000	+3%	+$347K	4.6%	6
2025 Q1	$10.3M	Buy	4,778,040 +125,000	+3%	+$395K	3.31%	9
2024 Q4	$18M	Buy	4,653,040 +486,211	+12%	+$3.21M	4.15%	10
2024 Q3	$27.3M	Buy	4,166,829 +307,361	+8%	+$2.47M	5.29%	7
2024 Q2	$28M	Sell	3,859,468 -135,000	-3%	-$1.03M	7.78%	5
2024 Q1	$30.3M	Buy	3,994,468 +580,000	+17%	+$4.52M	6.06%	8
2023 Q4	$15.5M	Buy	+3,414,468	New	+$11.5M	3.71%	9